Dr. Michael Scally’s education includes a double degree major in Chemistry (1975) and Life Sciences (1975) from the Massachusetts Institute of Technology (M.I.T.) and in 1980 was awarded an MD by Harvard Medical School. His clinical care, research, and investigations early on recognized the lack treatment for anabolic steroid induced hypogonadism [ASIH] occurring after stopping androgen use, both licit and illicit. He has treated ASIH for over two decades and presented and published the findings in the peer reviewed literature and professional organizations.